During the ICD response in tumor cells, HMGB1 is released extracellularly to bind to pattern recognition receptors (PRRs), including Toll-like receptors and receptors of advanced glycation end products (RAGE) (30). This evidence concerns the gene HMGB1 and neoplasm.